Anna Zagórska

机构：Gilead Sciences (United States) · ORCID：0000-0003-3703-1364

发表论文 68 篇 · 总被引 4509 次 · h-index 25

代表论文

• Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis (2019 · Cell Reports · 被引 436)
• Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation (2020 · Journal of Hepatology · 被引 230)
• ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model (2020 · JCI Insight · 被引 76)
• Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer (2020 · Life Science Alliance · 被引 41)
• Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors (2021 · Science Translational Medicine · 被引 25)
• Radiation Exposure of Surgical Team During Endourological Procedures: International Atomic Energy Agency–South-Eastern European Group for Urolithiasis Research Study (2020 · Journal of Endourology · 被引 24)